PETER HARWIN

Corporate Board Profile

Tech Score: 0/100

Oruka Therapeutics, Inc.

Filing Date	Source Excerpt
2024-10-18	Peter Harwin is a director of the Company and a managing member of Fairmount Funds Management LLC (“Fairmount”). Pursuant to the Purchase Agreement, Fairmount Healthcare Fund II L.P. (“Fairmount Fund II”) purchased 275,000 shares of common stock at a purchase price of $23.00 per share and 160 shares of Series A Preferred Stock at $23,000 per share for an aggregate purchase price of approximately $10,000,000 in the Private Placement.

Filing Date

Source Excerpt

2024-10-18

Peter Harwin is a director of the Company and a managing member of Fairmount Funds Management LLC (“Fairmount”). Pursuant to the Purchase Agreement, Fairmount Healthcare Fund II L.P. (“Fairmount Fund II”) purchased 275,000 shares of common stock at a purchase price of $23.00 per share and 160 shares of Series A Preferred Stock at $23,000 per share for an aggregate purchase price of approximately $10,000,000 in the Private Placement.

Data sourced from SEC filings. Last updated: 2026-02-03